Cargando…
FABREX: A NEW CLINICAL TEST FOR DIAGNOSIS GLUTEAL TENDINOPATHY
OBJECTIVE: This study aims to describe a simple and accurate semiological method executing a specific maneuver with the lower limb to direct the semiological investigation towards the tendinopathies in the gluteus medius and minimus. METHODS: Fifty patients participated in the study, with a mean age...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
ATHA EDITORA
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210511/ https://www.ncbi.nlm.nih.gov/pubmed/35765571 http://dx.doi.org/10.1590/1413-785220223002241045 |
_version_ | 1784730172935634944 |
---|---|
author | FREITAS, ANDERSON ROSA, TATIANE MORELATI MACEDO NETO, SILVIO LEITE DE BANDEIRA, VANESSA DE CARVALHO SOUTO, DIOGO RANIER DE MACEDO BARIN, FABRÍCIO REICHERT |
author_facet | FREITAS, ANDERSON ROSA, TATIANE MORELATI MACEDO NETO, SILVIO LEITE DE BANDEIRA, VANESSA DE CARVALHO SOUTO, DIOGO RANIER DE MACEDO BARIN, FABRÍCIO REICHERT |
author_sort | FREITAS, ANDERSON |
collection | PubMed |
description | OBJECTIVE: This study aims to describe a simple and accurate semiological method executing a specific maneuver with the lower limb to direct the semiological investigation towards the tendinopathies in the gluteus medius and minimus. METHODS: Fifty patients participated in the study, with a mean age of 44.1 ± 13 years, with persistent pain on the side of the hip for more than three months. To compare the FABREX (proposed test) and Lequesne semiological tests, in the diagnosis of tendinopathies in the gluteus medius and minimus, Magnetic Resonance Imaging (MRI) was adopted as the gold standard. RESULTS: FABREX presented high sensitivity and moderate specificity for tendinopathy in the gluteus medius and high sensitivity and specificity for tendinopathy in the gluteus minimus. CONCLUSION: The proposed test, when positive, can be used to determine the diagnosis of gluteal tendinopathies (high specificity). Moreover, it has high sensitivity, excluding the diagnosis when negative. This study represents the initial step for validating the FABREX test, and can therefore be considered a simple and accurate procedure to identify patients with or without gluteal tendinopathies. Level of Evidence III, Case Control Study. |
format | Online Article Text |
id | pubmed-9210511 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | ATHA EDITORA |
record_format | MEDLINE/PubMed |
spelling | pubmed-92105112022-06-27 FABREX: A NEW CLINICAL TEST FOR DIAGNOSIS GLUTEAL TENDINOPATHY FREITAS, ANDERSON ROSA, TATIANE MORELATI MACEDO NETO, SILVIO LEITE DE BANDEIRA, VANESSA DE CARVALHO SOUTO, DIOGO RANIER DE MACEDO BARIN, FABRÍCIO REICHERT Acta Ortop Bras Original Article OBJECTIVE: This study aims to describe a simple and accurate semiological method executing a specific maneuver with the lower limb to direct the semiological investigation towards the tendinopathies in the gluteus medius and minimus. METHODS: Fifty patients participated in the study, with a mean age of 44.1 ± 13 years, with persistent pain on the side of the hip for more than three months. To compare the FABREX (proposed test) and Lequesne semiological tests, in the diagnosis of tendinopathies in the gluteus medius and minimus, Magnetic Resonance Imaging (MRI) was adopted as the gold standard. RESULTS: FABREX presented high sensitivity and moderate specificity for tendinopathy in the gluteus medius and high sensitivity and specificity for tendinopathy in the gluteus minimus. CONCLUSION: The proposed test, when positive, can be used to determine the diagnosis of gluteal tendinopathies (high specificity). Moreover, it has high sensitivity, excluding the diagnosis when negative. This study represents the initial step for validating the FABREX test, and can therefore be considered a simple and accurate procedure to identify patients with or without gluteal tendinopathies. Level of Evidence III, Case Control Study. ATHA EDITORA 2022-04-15 /pmc/articles/PMC9210511/ /pubmed/35765571 http://dx.doi.org/10.1590/1413-785220223002241045 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License |
spellingShingle | Original Article FREITAS, ANDERSON ROSA, TATIANE MORELATI MACEDO NETO, SILVIO LEITE DE BANDEIRA, VANESSA DE CARVALHO SOUTO, DIOGO RANIER DE MACEDO BARIN, FABRÍCIO REICHERT FABREX: A NEW CLINICAL TEST FOR DIAGNOSIS GLUTEAL TENDINOPATHY |
title | FABREX: A NEW CLINICAL TEST FOR DIAGNOSIS GLUTEAL TENDINOPATHY |
title_full | FABREX: A NEW CLINICAL TEST FOR DIAGNOSIS GLUTEAL TENDINOPATHY |
title_fullStr | FABREX: A NEW CLINICAL TEST FOR DIAGNOSIS GLUTEAL TENDINOPATHY |
title_full_unstemmed | FABREX: A NEW CLINICAL TEST FOR DIAGNOSIS GLUTEAL TENDINOPATHY |
title_short | FABREX: A NEW CLINICAL TEST FOR DIAGNOSIS GLUTEAL TENDINOPATHY |
title_sort | fabrex: a new clinical test for diagnosis gluteal tendinopathy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210511/ https://www.ncbi.nlm.nih.gov/pubmed/35765571 http://dx.doi.org/10.1590/1413-785220223002241045 |
work_keys_str_mv | AT freitasanderson fabrexanewclinicaltestfordiagnosisglutealtendinopathy AT rosatatianemorelati fabrexanewclinicaltestfordiagnosisglutealtendinopathy AT macedonetosilvioleitede fabrexanewclinicaltestfordiagnosisglutealtendinopathy AT bandeiravanessadecarvalho fabrexanewclinicaltestfordiagnosisglutealtendinopathy AT soutodiogoranierdemacedo fabrexanewclinicaltestfordiagnosisglutealtendinopathy AT barinfabricioreichert fabrexanewclinicaltestfordiagnosisglutealtendinopathy |